Australia/Canberra:
BlueSkyGreenEarth Herbs Pty Ltd., an Alexandria, New South Wales establishment, recalls certain batch/lots of AntiBioBotanical and Ly)mex Herb medications from the Australian marketplace due to suspected Artemisia ingredients and consequential risks of health damage to women of childbearing age and to the health and/or safety of their developing fetus, including reproductive damage, all serious health hazards.
ACCC: http://ht.ly/ewNA30rCFEO
Direct link: https://www.productsafety.gov.au/recall/blueskygreenearth-herbs-pty-ltd-antibiobotanical-and-lymex
Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following drug products are subject to this recall:
Filed under: ACCC, Artemisia, Australia Therapeutic Goods Administration ("TGA"), Dietary Supplements, Drugs, Genotoxic hazard, Labeling or regulatory issues, Medical / Veterinary, mutagenic, TGA | Tagged: ACCC, ACCC PRA number: 2021/18924, Artemisia, Australian Competition & Consumer Commission, BlueSkyGreenEarth Herbs Pty, child, developmental delay hazard, dietary supplement, drug, fetus, genotoxicity hazard, medication, nutritional supplement, pregnant, Recalls Direct RIN: 14262-2021, Reproductive Damage hazard, TGA, Therapeutic Goods Administration | Leave a comment »